Deerfield Drug Discovery and Development

American drug discovery and development arm of Deerfield Management, the healthcare investment firm in New York, known as 3DC. Provides turnkey discovery and preclinical development for small molecules and biologics to Deerfield backed founders and companies, taking programmes from target validation through preclinical proof of concept and into the clinic with in house biotechnology and pharmaceutical veterans, and supports the firm's university research collaborations such as Hyde Park Discovery with the University of Chicago and VeritaScience with Washington University, and a strategic research partnership with Syngene.